{"id":"W2331971860","doi":"10.1016/s1499-2671(09)33272-4","title":"A time course analysis of glycaemic improvements with albiglutide, a long-acting GLP-1-receptor agonist for the treatment of type 2 diabetes","year":2009,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Glycemic; Dosing; Metformin; Placebo; Exenatide; Type 2 diabetes; Agonist; Dulaglutide; Pharmacokinetics; Internal medicine; Diabetes mellitus; Insulin; Endocrinology; Receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046283,0.0003438176,0.001127371,0.0002801786,0.0001847289,0.0003653695,0.0002294098,0.0004684236,0.00158268],"category_scores_gemma":[0.0007448196,0.0001404839,0.0005704049,0.0003905971,0.00023464,0.0003368516,0.0001577228,0.00110788,0.000220159],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002697676,"about_ca_system_score_gemma":0.0003621961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002522799,"about_ca_topic_score_gemma":0.002688241,"domain_scores_codex":[0.9998041,0.0000426456,0.00001304226,0.00004111381,0.00004137207,0.00005781765],"domain_scores_gemma":[0.9995683,0.0001170263,0.00007414089,0.00004163876,0.00005265355,0.000146262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5714114,0.009824637,0.01715742,0.0002273662,0.0007287579,0.0002516786,0.0001570374,0.001295316,0.3347846,0.000130671,0.001143071,0.06288799],"study_design_scores_gemma":[0.01065655,0.2299127,0.6080103,0.00003015971,0.001721951,0.000515396,0.0002246561,0.007815072,0.1379921,0.0001797262,0.002815088,0.0001262669],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969009,0.001004802,0.0003498245,0.00005212232,0.00005333883,0.00009217116,0.0008607684,0.00002856719,0.0006574803],"genre_scores_gemma":[0.9973143,0.0003865921,0.0004204074,0.00007716441,0.00002931905,0.0000748981,0.000806177,0.000009718983,0.0008814303],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002522799,"threshold_uncertainty_score":0.005294621,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0108251323338881,"score_gpt":0.2440287238267652,"score_spread":0.2332035914928771,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}